Tuberculosis News and Research

Latest Tuberculosis News and Research

Investigators, CTUs chosen to lead five HIV/AIDS clinical trials networks through 2021

Principal investigators and clinical trials units have been chosen to lead and conduct the research of five HIV/AIDS clinical trials networks through 2021. The effort is directed and funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Total funding for the networks' leadership and the CTUs is expected to reach $225 million in 2014, the first year of operation.

17 Dec 2013

BWH receives $140M grant from NIAID to support ongoing research led by AIDS Clinical Trial Group

The National Institute of Allergy and Infectious Diseases has awarded two seven-year grants to Brigham and Women's Hospital to fund the AIDS Clinical Trial Group Network.

16 Dec 2013

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Janssen Research & Development, LLC (Janssen) today announced it has received from the U.S. Food and Drug Administration (FDA) a complete response letter regarding its New Drug Application (NDA) for a fixed-dose combination (FDC) of canagliflozin and immediate-release metformin to treat adults with type 2 diabetes.

16 Dec 2013

Pregnant women, infants should avoid unpasteurized milk products, urge pediatricians

Pregnant women, infants and young children should avoid raw or unpasteurized milk and milk products and only consume pasteurized products, according to a new policy statement from the American Academy of Pediatrics.

16 Dec 2013

Findings could point the way to new vaccines to prevent Mycobacterium tuberculosis

The lung lesions in an individual infected with tuberculosis are surprisingly variable and independent of each other, despite whether the patient has clinically active or latent disease, according to a new animal study led by researchers at the University of Pittsburgh School of Medicine. The findings, published online today in Nature Medicine, could point the way to new vaccines to prevent the hard-to-treat infection.

16 Dec 2013

Viewpoints: Problems with the 'doc fix;' a lame budget deal; concerns about changes in doctor training

Imagine if a provision in ObamaCare allowed Health and Human Services Secretary Kathleen Sebelius to dictate directly to doctors which services they could and could not provide their patients - what individual tests they could conduct, which treatments they could offer, and medicines they could prescribe.

13 Dec 2013

WHO hands over management of world's largest public collection of TB strains to ITM in Antwerp

The World Health Organisation handed over the management of the world's largest public collection of tuberculosis strains to the Institute of Tropical Medicine in Antwerp. These TB-strains play a key role in supporting scientific research into infectious diseases, particularly towards a better understanding of the TB bacterium's drug resistance.

13 Dec 2013

UCSF receives $15M grant to help three dozen countries eliminate malaria

UC San Francisco's Global Health Group has received a $15 million grant from the Bill & Melinda Gates Foundation for a pioneering effort to help nearly three dozen countries eliminate malaria within their borders.

13 Dec 2013

Results-Based Financing for Health can get 20% more health care with same funds

Countries and major donors are changing the way they finance maternal and child, malaria, tuberculosis and HIV/AIDS health programs in low-income countries to increase their impact.

11 Dec 2013

Otsuka, Lundbeck to develop investigational vaccine candidate for Alzheimer's disease

H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that they will further expand their collaboration to include the development of Lu AF20513, an investigational vaccine candidate for Alzheimer's disease.

11 Dec 2013

Study finds large degree of genetic variation amongst M. tuberculosis in humans in Zambia

In Zambia, the incidence of all forms of human tuberculosis is estimated to be 444 per 100,000. There is also a high incidence of HIV and AIDS in the country. In the Kafue area, a high incidence of Mycobacterium bovis in both cattle and the Kafue lechwe antilope has been detected. This bacterium can infect humans and has been found in humans in the studied region of Namwala. Mycobacterium tuberculosis, which is the main cause of human tuberculosis, has also been detected in cattle in this region.

10 Dec 2013

Janssen announces first-of-its-kind pediatric HIV treatment donation program

Janssen, the pharmaceutical companies of Johnson & Johnson, today announced a first-of-its-kind pediatric HIV treatment donation program to improve access to the company's approved HIV medicines for children and adolescents failing HIV treatment in sub-Saharan Africa.

9 Dec 2013

Ancon Technologies unveils new cancer-screening device

Ancon Technologies, a company devoted to finding new ways to beat cancer, recently unveiled a new cancer-screening device to the public, the NBT detector. The company's latest product aims to bring cancer detection to the next level: it uses Nanoparticle Biomarker Tagging technology to identify cancer biomarkers in exhaled air.

6 Dec 2013

TB vaccine may help prevent multiple sclerosis

A vaccine used to prevent tuberculosis in other parts of the world may help prevent multiple sclerosis in people who show the beginning signs of the disease, according to a new study published in the December 4, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.

5 Dec 2013

Tackling orphan diseases: an interview with Damian Marron, CEO, TxCell

The exact definition of orphan diseases varies depending on where you are in the world. In the EU it's defined as a prevalence of less than 1 in 2,000, which equates to about 250,000 patients across the EU.

4 Dec 2013

Lucane Pharma, Medunik Canada to offer new therapeutic option for patients suffering from UCD

Medunik Canada, a pharmaceutical company specialized in orphan drugs and Lucane Pharma, a French niche pharmaceutical company, announced the conclusion of an exclusive collaboration agreement.

4 Dec 2013

Pyridomycin turns out to be a lethal weapon against TB

Technology has made it possible to synthesize increasingly targeted drugs. But scientists still have much to learn from Mother Nature. Pyridomycin, a substance produced by non-pathogenic soil bacteria, has been found to be a potent antibiotic against a related strain of bacteria that cause tuberculosis.

4 Dec 2013

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis will present updates on its broad cancer portfolio with more than 240 abstracts at the upcoming American Society of Hematology (ASH) annual meeting and CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).

4 Dec 2013

AHF commends donors for rallying to pledge financial support for Global Fund

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, today heartily praised donor countries for rallying to pledge financial support for the Global Fund to Fight AIDS, TB, and Malaria.

4 Dec 2013

EU pledges over $500 million to fight AIDS, TB and malaria

The European Union today announced at the Global Fund's Replenishment Conference in Washington, DC, new support of over US $500 million to fight AIDS, tuberculosis and malaria for the 2014-2016 period. The conference takes place just one day after World AIDS Day.

3 Dec 2013

Tuberculosis News and Research

Latest Tuberculosis News and Research

Investigators, CTUs chosen to lead five HIV/AIDS clinical trials networks through 2021

BWH receives $140M grant from NIAID to support ongoing research led by AIDS Clinical Trial Group

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Pregnant women, infants should avoid unpasteurized milk products, urge pediatricians

Findings could point the way to new vaccines to prevent Mycobacterium tuberculosis

Viewpoints: Problems with the 'doc fix;' a lame budget deal; concerns about changes in doctor training

WHO hands over management of world's largest public collection of TB strains to ITM in Antwerp

UCSF receives $15M grant to help three dozen countries eliminate malaria

Results-Based Financing for Health can get 20% more health care with same funds

Otsuka, Lundbeck to develop investigational vaccine candidate for Alzheimer's disease

Study finds large degree of genetic variation amongst M. tuberculosis in humans in Zambia

Janssen announces first-of-its-kind pediatric HIV treatment donation program

Ancon Technologies unveils new cancer-screening device

TB vaccine may help prevent multiple sclerosis

Tackling orphan diseases: an interview with Damian Marron, CEO, TxCell

Lucane Pharma, Medunik Canada to offer new therapeutic option for patients suffering from UCD

Pyridomycin turns out to be a lethal weapon against TB

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

AHF commends donors for rallying to pledge financial support for Global Fund

EU pledges over $500 million to fight AIDS, TB and malaria

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Tuberculosis News and Research

Latest Tuberculosis News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in